Search Results | Diabetes Care | American Diabetes Association

1-20 of 31

Sort by

Sort Order Select

Journal Articles

Short Leg Length, a Marker of Early Childhood Deprivation, Is Associated With Metabolic Disorders Underlying Type 2 Diabetes: The PROMISE cohort study

Luke W. Johnston, BSC, Stewart B. Harris, MD, Ravi Retnakaran, MD, Hertzel C. Gerstein, MD, Bernard Zinman, MD, Jill Hamilton, MD, Anthony J. Hanley, PHD

Diabetes Care 2013;36(11):3599–3606

DOI: https://doi.org/10.2337/dc13-0254

Published: 15 October 2013

View article

Journal Articles

Effect of Insulin Glargine and n-3FA on Carotid Intima-Media Thickness in People With Dysglycemia at High Risk for Cardiovascular Events: The Glucose Reduction and Atherosclerosis Continuing Evaluation Study (ORIGIN-GRACE)

Eva M. Lonn, MD, Jackie Bosch, MSC, Rafael Diaz, MD, Patricio Lopez-Jaramillo, MD, Ambady Ramachandran, MD, Nicolae Hâncu, MD, PHD, Markolf Hanefeld, MD, Henry Krum, MBBS, PHD, Lars Ryden, MD, PHD, Sandra Smith, RDMS, Matthew J. McQueen, MD, PHD, Leanne Dyal, MSC, Salim Yusuf, MD, DPHIL, Hertzel C. Gerstein, MD, for the GRACE and ORIGIN Investigators

Diabetes Care 2013;36(9):2466–2474

DOI: https://doi.org/10.2337/dc12-2129

Published: 13 August 2013

View article

Includes: Supplementary data

Journal Articles

Determinants of Weight Gain in the Action to Control Cardiovascular Risk in Diabetes Trial

Vivian Fonseca, MD, Roberta McDuffie, MSN, Jorge Calles, MD, Robert M. Cohen, MD, Patricia Feeney, MS, Mark Feinglos, MD, Hertzel C. Gerstein, MD, Faramarz Ismail-Beigi, MD, Timothy M. Morgan, PHD, Rodica Pop-Busui, MD, Matthew C. Riddle, MD, the ACCORD Study Group

Diabetes Care 2013;36(8):2162–2168

DOI: https://doi.org/10.2337/dc12-1391

Published: 11 July 2013

View article

Includes: Supplementary data

Journal Articles

Diabetic Retinopathy, Its Progression, and Incident Cardiovascular Events in the ACCORD Trial

Hertzel C. Gerstein, MD, Walter T. Ambrosius, PHD, Ronald Danis, MD, Faramarz Ismail-Beigi, MD, William Cushman, MD, Jorge Calles, MD, MaryAnn Banerji, MD, Ulrich Schubart, MD, Emily Y. Chew, MD, for the ACCORD Study Group

Diabetes Care 2013;36(5):1266–1271

DOI: https://doi.org/10.2337/dc12-1311

Published: 13 April 2013

View article

Includes: Supplementary data

Journal Articles

Poor Cognitive Function and Risk of Severe Hypoglycemia in Type 2 Diabetes: Post hoc epidemiologic analysis of the ACCORD trial

Zubin Punthakee, MD, Michael E. Miller, PHD, Lenore J. Launer, PHD, Jeff D. Williamson, MD, Ronald M. Lazar, PHD, Tali Cukierman-Yaffee, MD, Elizabeth R. Seaquist, MD, Faramarz Ismail-Beigi, MD, Mark D. Sullivan, MD, Laura C. Lovato, MS, Richard M. Bergenstal, MD, Hertzel C. Gerstein, MD, for the ACCORD Group of Investigators and the ACCORD-MIND Investigators

Diabetes Care 2012;35(4):787–793

DOI: https://doi.org/10.2337/dc11-1855

Published: 13 March 2012

View article

Includes: Supplementary data

Journal Articles

Relationship Between A1C and Fasting Plasma Glucose in Dysglycemia or Type 2 Diabetes: An analysis of baseline data from the ORIGIN trial

Ambady Ramachandran, MD, Matthew C. Riddle, MD, Conrad Kabali, PHD, Hertzel C. Gerstein, MD, on behalf of the ORIGIN Investigators

Diabetes Care 2012;35(4):749–753

DOI: https://doi.org/10.2337/dc11-1918

Published: 13 March 2012

View article

Includes: Supplementary data

Journal Articles

Piloting a Novel Algorithm for Glucose Control in the Coronary Care Unit: The RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) trial

Kara A. Nerenberg, MD, Abhinav Goyal, MD, Denis Xavier, MBBS, Alben Sigamani, MBBS, Jennifer Ng, MSC, Shamir R. Mehta, MD, Rafael Díaz, MD, Mikhail Kosiborod, MD, Salim Yusuf, PHD, Hertzel C. Gerstein, MD, for the RECREATE Investigators

Diabetes Care 2012;35(1):19–24

DOI: https://doi.org/10.2337/dc11-0706

Published: 09 December 2011

View article

Includes: Supplementary data

Journal Articles

Effect of Computer-Generated Tailored Feedback on Glycemic Control in People With Diabetes in the Community: A randomized controlled trial

Diana Sherifali, RN, Janet L. Greb, MPA, Gaya Amirthavasar, MSC, Dereck Hunt, MD, R. Brian Haynes, MD, William Harper, MD, Anne Holbrook, MD, Sarah Capes, MD, Ron Goeree, MA, Daria O’Reilly, PHD, Eleanor Pullenayegum, PHD, Hertzel C. Gerstein, MD

Diabetes Care 2011;34(8):1794–1798

DOI: https://doi.org/10.2337/dc11-0006

Published: 16 July 2011

View article

Includes: Supplementary data

Journal Articles

Variation at the NFATC2 Locus Increases the Risk of Thiazolidinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study

Swneke D. Bailey, BSC, Changchun Xie, PHD, Ron Do, MSC, Alexandre Montpetit, PHD, Rafael Diaz, MD, Viswanathan Mohan, MD, PHD, DSC, FRCP, Bernard Keavney, MD, FRCP, Salim Yusuf, MD, DPHIL, FRCPC, Hertzel C. Gerstein, MD, MSC, FRCPC, James C. Engert, PHD, Sonia Anand, MD, PHD, FRCPC, on behalf of the DREAM investigators

Diabetes Care 2010;33(10):2250–2253

DOI: https://doi.org/10.2337/dc10-0452

Published: 13 July 2010

View article

Includes: Supplementary data

Journal Articles

The Effect of Oral Antidiabetic Agents on A1C Levels: A systematic review and meta-analysis

Diana Sherifali, RN, PHD, CDE, Kara Nerenberg, MD, MSC, FRCPC, Eleanor Pullenayegum, PHD, Ji Emmy Cheng, MSC, Hertzel C. Gerstein, MD, MSC, FRCPC

Diabetes Care 2010;33(8):1859–1864

DOI: https://doi.org/10.2337/dc09-1727

Published: 18 May 2010

View article

Includes: Supplementary data

Journal Articles

Association of Vitamin D With Insulin Resistance and β-Cell Dysfunction in Subjects at Risk for Type 2 Diabetes

Sheena Kayaniyil, MSC, Reinhold Vieth, PHD, Ravi Retnakaran, MD, Julia A. Knight, PHD, Ying Qi, MSC, Hertzel C. Gerstein, MD, Bruce A. Perkins, MD, Stewart B. Harris, MD, Bernard Zinman, MD, Anthony J. Hanley, PHD

Diabetes Care 2010;33(6):1379–1381

DOI: https://doi.org/10.2337/dc09-2321

Published: 09 March 2010

View article

Includes: Supplementary data

Journal Articles

Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

Rodica Pop-Busui, MD, PHD, Gregory W. Evans, MA, Hertzel C. Gerstein, MD, MSC, Vivian Fonseca, MD, Jerome L. Fleg, MD, Byron J. Hoogwerf, MD, Saul Genuth, MD, Richard H. Grimm, MD, PHD, Marshall A. Corson, MD, Ronald Prineas, MD, the ACCORD Study Group

Diabetes Care 2010;33(7):1578–1584

DOI: https://doi.org/10.2337/dc10-0125

Published: 09 March 2010

View article

Includes: Supplementary data

Journal Articles

A 24-Week, Randomized, Treat-to-Target Trial Comparing Initiation of Insulin Glargine Once-Daily With Insulin Detemir Twice-Daily in Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs

Sanne G. Swinnen, MD, Marie-Paule Dain, MD, Ronnie Aronson, MD, Melanie Davies, MD, Hertzel C. Gerstein, MD, Andreas F. Pfeiffer, MD, PHD, Frank J. Snoek, PHD, J. Hans DeVries, MD, PHD, Joost B. Hoekstra, MD, PHD, Frits Holleman, MD, PHD

Diabetes Care 2010;33(6):1176–1178

DOI: https://doi.org/10.2337/dc09-2294

Published: 03 March 2010

View article

Includes: Supplementary data

Journal Articles

Effect of Rosiglitazone and Ramipril on β-Cell Function in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: The DREAM trial

Anthony J. Hanley, PHD, Bernard Zinman, MD, Patrick Sheridan, PHD, Salim Yusuf, MD, Hertzel C. Gerstein, MD, for the Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication (DREAM) Investigators

Diabetes Care 2010;33(3):608–613

DOI: https://doi.org/10.2337/dc09-1579

Published: 15 December 2009

View article

Includes: Supplementary data

Journal Articles

Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

David Preiss, MRCP, Sofia Zetterstrand, PHD, John J.V. McMurray, MD, Jan Östergren, MD, Eric L. Michelson, MD, Christopher B. Granger, MD, Salim Yusuf, MB BS, DPHIL, Karl Swedberg, MD, PHD, Marc A. Pfeffer, MD, PHD, Hertzel C. Gerstein, MD, Naveed Sattar, PHD, for the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity Investigators

Diabetes Care 2009;32(5):915–920

DOI: https://doi.org/10.2337/dc08-1709

Published: 05 February 2009

View article

Journal Articles

Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors: The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) trial

Tali Cukierman-Yaffe, MD, MSC, Hertzel C. Gerstein, MD, MSC, Jeff D. Williamson, MD, MPH, Ronald M. Lazar, PHD, Laura Lovato, MS, Michael E. Miller, PHD, Laura H. Coker, PHD, Anne Murray, MD, Mark D. Sullivan, MD, PHD, Santica M. Marcovina, PHD, SCD, Lenore J. Launer, PHD, for the Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Investigators

Diabetes Care 2009;32(2):221–226

DOI: https://doi.org/10.2337/dc08-1153

Published: 01 February 2009

View article

Journal Articles

Dysglycemia and a History of Reproductive Risk Factors

Sarah D. McDonald, MD, MSC, Salim Yusuf, MD, DPHIL, Patrick Sheridan, MSC, Sonia S. Anand, MD, PHD, Hertzel C. Gerstein, MD, MSC, for the DREAM Trial Investigators

Diabetes Care 2008;31(8):1635–1638

DOI: https://doi.org/10.2337/dc08-0621

Published: 01 August 2008

View article

Journal Articles

Point: If It Is Important to Prevent Type 2 Diabetes, It Is Important to Consider All Proven Therapies Within a Comprehensive Approach

Hertzel C. Gerstein, MD, MSC, FRCPC

Diabetes Care 2007;30(2):432–434

DOI: https://doi.org/10.2337/dc06-2147

Published: 01 February 2007

View article

Journal Articles

A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events: A comparison of glyburide with other secretagogues and with insulin

Azim S. Gangji, MD, FRCPC, Tali Cukierman, MD, Hertzel C. Gerstein, MD, FRCPC, Charles H. Goldsmith, PHD, Catherine M. Clase, MB, FRCPC

Diabetes Care 2007;30(2):389–394

DOI: https://doi.org/10.2337/dc06-1789

Published: 01 February 2007

View article

Includes: Supplementary data

Journal Articles

The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes: Response to Monnier et al., the Diabetes Research in Children Network (DirecNet) Study Group, and Irsch and Brownlee

Geremia B. Bolli, MD, Hertzel C. Gerstein, MD, Julio Rosenstock, MD

Diabetes Care 2007;30(1):188–189

DOI: https://doi.org/10.2337/dc06-2073x

Published: 01 January 2007

View article

NARROW

Short Leg Length, a Marker of Early Childhood Deprivation, Is Associated With Metabolic Disorders Underlying Type 2 Diabetes: The PROMISE cohort study

Effect of Insulin Glargine and n-3FA on Carotid Intima-Media Thickness in People With Dysglycemia at High Risk for Cardiovascular Events: The Glucose Reduction and Atherosclerosis Continuing Evaluation Study (ORIGIN-GRACE)

Determinants of Weight Gain in the Action to Control Cardiovascular Risk in Diabetes Trial

Diabetic Retinopathy, Its Progression, and Incident Cardiovascular Events in the ACCORD Trial

Poor Cognitive Function and Risk of Severe Hypoglycemia in Type 2 Diabetes: Post hoc epidemiologic analysis of the ACCORD trial

Relationship Between A1C and Fasting Plasma Glucose in Dysglycemia or Type 2 Diabetes: An analysis of baseline data from the ORIGIN trial

Piloting a Novel Algorithm for Glucose Control in the Coronary Care Unit: The RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) trial

Effect of Computer-Generated Tailored Feedback on Glycemic Control in People With Diabetes in the Community: A randomized controlled trial

Variation at the NFATC2 Locus Increases the Risk of Thiazolidinedione-Induced Edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) Study

The Effect of Oral Antidiabetic Agents on A1C Levels: A systematic review and meta-analysis

Association of Vitamin D With Insulin Resistance and β-Cell Dysfunction in Subjects at Risk for Type 2 Diabetes

Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

A 24-Week, Randomized, Treat-to-Target Trial Comparing Initiation of Insulin Glargine Once-Daily With Insulin Detemir Twice-Daily in Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs

Effect of Rosiglitazone and Ramipril on β-Cell Function in People With Impaired Glucose Tolerance or Impaired Fasting Glucose: The DREAM trial

Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors: The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) trial

Dysglycemia and a History of Reproductive Risk Factors

Point: If It Is Important to Prevent Type 2 Diabetes, It Is Important to Consider All Proven Therapies Within a Comprehensive Approach

A Systematic Review and Meta-Analysis of Hypoglycemia and Cardiovascular Events: A comparison of glyburide with other secretagogues and with insulin

The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes: Response to Monnier et al., the Diabetes Research in Children Network (DirecNet) Study Group, and Irsch and Brownlee

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only